跳至主要内容
临床试验/NL-OMON24444
NL-OMON24444招募中不适用

Probiotic formulation for patients with psychotic or bipolar disorder who have screened positive for increased intestinal permeability

Prof. Dr. I.E.C. Sommer Universitair Medisch Centrum GroningenDepartment of Neuroscience i.e.c.sommer@umcg.nl0 个研究点目标入组 145 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
145

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1.Age = 18
  • 2.The participant understands the study and is capable of providing written informed consent
  • 3.The participant has a DSM-IV-R or DSM-5 diagnosis of: 295.x (schizophrenia, schizophreniform disorder or schizo-affective disorder) or bipolar disorder 296.x

排除标准

  • 1.Pregnancy or breastfeeding (assessed through anamnesis)
  • 2.Mental retardation (IQ score <60)
  • 3.Active liver-, kidney- or pancreas disease as defined by alanine amino transferase (ALAT) levels more than two times the upper boundary of normal levels
  • 4.Any clinically significant or unstable medical disorder as determined by the investigators, including inflammatory bowel disease, short-bowel syndrome or acute/chronic pancreatitis

研究者

发起方
Prof. Dr. I.E.C. Sommer Universitair Medisch Centrum GroningenDepartment of Neuroscience i.e.c.sommer@umcg.nl

相似试验

Probiotic formulation for patients with psychotic or... | 临床试验